The Association of ADAMTS7 Gene Polymorphisms with the Risk of Coronary Artery Disease Occurrence and Cardiovascular Survival in the Polish Population: A Case-Control and a Prospective Cohort Study.
Joanna IwanickaAnna BalcerzykTomasz IwanickiKatarzyna Mizia-StecPaweł BańkaArtur FilipeckiKatarzyna GawronAlicja JaroszTomasz NowakJolanta KrauzePaweł NiemiecPublished in: International journal of molecular sciences (2024)
The aim of this study was to investigate whether the polymorphisms of the ADAMTS7 gene affect the risk of occurrence and mortality due to CAD. The study group included 231 patients diagnosed with CAD and 240 control blood donors. The genotyping of specified polymorphisms, i.e., rs1994016, rs3825807, and rs7173743, was performed using the TaqMan-PCR. We found that the C allele carriers of the rs1994016 and A allele carriers of the rs3825807 polymorphisms increased the risk of CAD, respectively: OR = 1.72, p = 0.036; OR = 1.64, p = 0.04. Moreover, we studied the biological interactions of specified variants, i.e., rs3825807, rs1994016, and rs7173743, and previously approved risk factors of CAD. We demonstrated here that selected polymorphisms of ADAMTS7 increased the risk of CAD altogether with abnormalities of total cholesterol and LDL concentrations in serum. Although survival analyses did not reveal statistical significance, we observed a trend for the AA genotype of the rs3825807 ADAMTS7 , which may predispose to death due to CAD in a 5-year follow-up. In conclusion, the ADAMTS7 polymorphisms investigated in this study may increase the risk of occurrence and/or death due to CAD in the Polish population.
Keyphrases
- coronary artery disease
- risk factors
- cardiovascular events
- risk assessment
- percutaneous coronary intervention
- genome wide
- end stage renal disease
- gene expression
- type diabetes
- heart failure
- copy number
- chronic kidney disease
- cardiovascular disease
- high resolution
- case control
- prognostic factors
- left ventricular
- atrial fibrillation
- aortic stenosis
- transcatheter aortic valve replacement
- low density lipoprotein
- patient reported
- atomic force microscopy